**Defibrillator Threshold Testing**

Munir Zaqqa

[28] Matl, F. D, Zlotnyk, J, Obermeier, A, Friess, W, Vogt, S, Buchner, H, Schnabelrauch, H, & Stemberger, A. Kuhn KD: New anti-infective coatings of surgical sutures based

[29] Wong, S. Y, Moskowitz, J. S, Veselinovic, J, Rosario, R. A, Timachova, K, Blaisse, M. R, Fuller, R. C, & Klibanov, A. M. Hammond PT: Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled re‐

[30] Bertaglia, E, Zerbo, F, Zardo, S, Barzan, D, & Zoppo, F. Pascotto P: Antibiotic pro‐ phylaxis with a single dose of cephazolin during pacemaker implantation: incidence

[31] Ferguson, T. B. Jr., Ferguson CL, Crites K, Crimmins-Reda P: The additional hospital costs generated in the management of complications of pacemaker and defibrillator

[32] Darouiche RO: Treatment of infections associated with surgical implants. (2004). *N*

[33] Dababneh, A. S. Sohail MR: Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management. *Cleve Clin J Med* (2011).

[34] Maytin, M. Epstein LM: Proof positive: efficacy of antibiotic prophylaxis in device

[35] Bluhm, G, & Jacobson, B. Ransjo U: Antibiotic prophylaxis in pacemaker surgery: a prospective trial with local or systemic administration of antibiotics at generator re‐

[36] De Oliveira, J. C, Martinelli, M, Nishioka, S. A, Varejao, T, Uipe, D, Pedrosa, A. A, Costa, R, Avila, D, & Danik, A. SB: Efficacy of antibiotic prophylaxis before the im‐ plantation of pacemakers and cardioverter-defibrillators: results of a large, prospec‐ tive, randomized, double-blinded, placebo-controlled trial. *Circ Arrhythm*

[37] Tarakji, K. G, Chan, E. J, Cantillon, D. J, Doonan, A. L, Hu, T, Schmitt, S, Fraser, T. G, Kim, A, & Gordon, S. M. Wilkoff BL: Cardiac implantable electronic device infec‐

[38] Sohail, M. R, Uslan, D. Z, Khan, A. H, Friedman, P. A, Hayes, D. L, Wilson, W. R, Steckelberg, J. M, & Stoner, S. Baddour LM: Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. *J Am Coll Cardiol*

tions: presentation, management, and patient outcomes. *Heart Rhythm* (2010).

of long-term infective complications. *Pacing Clin Electrophysiol* (2006).

implantations. *J Thorac Cardiovasc Surg* (1996). discussion , 751-742.

on a combination of antiseptics and fatty acids. *J Biomater Sci Polym Ed* (2009).

lease of therapeutic agents. *J Am Chem Soc* (2010).

implantation. *Circ Arrhythm Electrophysiol* (2009).

placements. *Pacing Clin Electrophysiol* (1985).

*Engl J Med*, .

120 Cardiac Defibrillation

*Electrophysiol* (2009).

(2007).

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/52594
